BRIGHT MINDS BIOSCIENCES INC. Cash Flows From Used In Financing Activities
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Cash Flows From Used In Financing Activities of CAD 810.57 thousand for the 12-month period ending 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2024-12-31
| Period end | Cash Flows From Used In Financing Activities 4 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|
| 2024-09-30 | 810.57K CAD 20-F · filed 2024-12-31 | |
| 2023-09-30 | 2.19M CAD 20-F · filed 2024-12-31 | |
| 2022-09-30 | 5.20M CAD 20-F · filed 2024-12-31 | |
| 2021-09-30 | 26.06M CAD 20-F · filed 2023-12-29 | |
| 2020-09-30 | 1.01M CAD 20-F · filed 2022-12-29 | |
| 2019-09-30 | 122.00K CAD 20-F/A · filed 2022-01-18 |